company background image
1099 logo

Sinopharm Group Informe acción SEHK:1099

Último precio

HK$19.22

Capitalización de mercado

HK$60.0b

7D

-2.9%

1Y

-20.2%

Actualizada

16 Jul, 2024

Datos

Finanzas de la empresa +

Sinopharm Group Co. Ltd.

Informe acción SEHK:1099

Capitalización de mercado: HK$60.0b

Resumen de acción 1099

Sinopharm Group Co. Ltd., junto con sus filiales, se dedica a la venta al por mayor y al por menor de productos farmacéuticos, dispositivos médicos y productos sanitarios en la República Popular China.

Acerca de la empresa

1099 análisis fundamental
Puntuación del copo de nieve
Valoración6/6
Crecimiento futuro1/6
Resultados anteriores2/6
Salud financiera4/6
Dividendos5/6

Recompensas

Cotiza un 46% por debajo de nuestra estimación de su valor justo
Se prevé un crecimiento anual de los beneficios de 6.6%
Los beneficios han crecido un 9% al año en los últimos 5 años
Paga dividendo fiable de 4.21%
Cotiza a buen valor en comparación con empresas similares e industria
Los analistas coinciden en que el precio de las acciones subirá un 21.1%

Análisis de riesgos

No se han detectado riesgos en 1099 a partir de nuestros controles de riesgos.

Competidores de Sinopharm Group Co. Ltd.

Guangzhou Baiyunshan Pharmaceutical Holdings

SEHK:874

HK$49.6b

Shanghai Pioneer Holding

SEHK:1345

HK$2.1b

Tycoon Group Holdings

SEHK:3390

HK$3.0b

IVD Medical Holding

SEHK:1931

HK$1.2b

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Sinopharm Group
Precios históricos de las acciones
Precio actual de la acciónHK$19.22
Máximo en 52 semanasHK$25.20
Mínimo de 52 semanasHK$17.44
Beta0.88
11 mes Cambio-12.83%
Variación en 3 meses-3.13%
Cambio de 1 año-20.25%
3Variación en 3 años-13.62%
Variación en 5 años-35.72%
Variación desde la OPV3.78%

Noticias y actualizaciones recientes

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Jun 16
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

May 13
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

Is Sinopharm Group (HKG:1099) A Risky Investment?

Apr 22
Is Sinopharm Group (HKG:1099) A Risky Investment?

Recent updates

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Jun 16
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To CN¥0.956

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

May 13
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 46% Discount?

Is Sinopharm Group (HKG:1099) A Risky Investment?

Apr 22
Is Sinopharm Group (HKG:1099) A Risky Investment?

Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital

Mar 21
Investors Could Be Concerned With Sinopharm Group's (HKG:1099) Returns On Capital

Should You Think About Buying Sinopharm Group Co. Ltd. (HKG:1099) Now?

Mar 06
Should You Think About Buying Sinopharm Group Co. Ltd. (HKG:1099) Now?

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 29% Discount?

Jan 31
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 29% Discount?

Is Sinopharm Group (HKG:1099) A Risky Investment?

Jan 15
Is Sinopharm Group (HKG:1099) A Risky Investment?

There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding

Dec 31
There Is A Reason Sinopharm Group Co. Ltd.'s (HKG:1099) Price Is Undemanding

Returns On Capital Signal Tricky Times Ahead For Sinopharm Group (HKG:1099)

Nov 29
Returns On Capital Signal Tricky Times Ahead For Sinopharm Group (HKG:1099)

If EPS Growth Is Important To You, Sinopharm Group (HKG:1099) Presents An Opportunity

Nov 14
If EPS Growth Is Important To You, Sinopharm Group (HKG:1099) Presents An Opportunity

Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 28% Discount?

Nov 01
Is Sinopharm Group Co. Ltd. (HKG:1099) Trading At A 28% Discount?

Should You Investigate Sinopharm Group Co. Ltd. (HKG:1099) At HK$22.45?

Sep 20
Should You Investigate Sinopharm Group Co. Ltd. (HKG:1099) At HK$22.45?

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Sep 05
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Aug 18
Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Are Sinopharm Group Co. Ltd. (HKG:1099) Investors Paying Above The Intrinsic Value?

Aug 02
Are Sinopharm Group Co. Ltd. (HKG:1099) Investors Paying Above The Intrinsic Value?

Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly

Jun 01
Sinopharm Group (HKG:1099) Seems To Use Debt Quite Sensibly

Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

Apr 26
Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Feb 27
These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Jan 19
Sinopharm Group (HKG:1099) Has Some Way To Go To Become A Multi-Bagger

Is Sinopharm Group (HKG:1099) A Risky Investment?

Nov 18
Is Sinopharm Group (HKG:1099) A Risky Investment?

Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Oct 03
Returns At Sinopharm Group (HKG:1099) Appear To Be Weighed Down

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Jul 31
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Jul 10
Estimating The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement

Jun 05
Slowing Rates Of Return At Sinopharm Group (HKG:1099) Leave Little Room For Excitement

We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Apr 11
We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Mar 21
A Look At The Fair Value Of Sinopharm Group Co. Ltd. (HKG:1099)

Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns

Mar 03
Sinopharm Group (HKG:1099) Hasn't Managed To Accelerate Its Returns

Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Jan 09
Is Sinopharm Group (HKG:1099) Using Too Much Debt?

Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price

Dec 19
Sinopharm Group Co., Ltd.'s (HKG:1099) Intrinsic Value Is Potentially 28% Above Its Share Price

Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

Dec 01
Returns On Capital At Sinopharm Group (HKG:1099) Have Stalled

These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

Sep 23
These 4 Measures Indicate That Sinopharm Group (HKG:1099) Is Using Debt Reasonably Well

A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)

Sep 10
A Look At The Fair Value Of Sinopharm Group Co., Ltd. (HKG:1099)

Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing

Aug 28
Return Trends At Sinopharm Group (HKG:1099) Aren't Appealing

Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84

Jun 13
Sinopharm Group (HKG:1099) Is Increasing Its Dividend To HK$0.84

Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Jun 06
Here's Why Sinopharm Group (HKG:1099) Can Manage Its Debt Responsibly

Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value

May 24
Is Sinopharm Group Co., Ltd. (HKG:1099) Expensive For A Reason? A Look At Its Intrinsic Value

Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

May 11
Sinopharm Group's (HKG:1099) Returns Have Hit A Wall

Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?

Mar 20
Have Insiders Been Selling Sinopharm Group Co., Ltd. (HKG:1099) Shares?

We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt

Mar 05
We Think Sinopharm Group (HKG:1099) Is Taking Some Risk With Its Debt

You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend

Feb 18
You Have To Love Sinopharm Group Co., Ltd.'s (HKG:1099) Dividend

Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?

Feb 03
Should You Be Impressed By Sinopharm Group's (HKG:1099) Returns on Capital?

Should You Use Sinopharm Group's (HKG:1099) Statutory Earnings To Analyse It?

Jan 19
Should You Use Sinopharm Group's (HKG:1099) Statutory Earnings To Analyse It?

At HK$19.00, Is It Time To Put Sinopharm Group Co., Ltd. (HKG:1099) On Your Watch List?

Jan 06
At HK$19.00, Is It Time To Put Sinopharm Group Co., Ltd. (HKG:1099) On Your Watch List?

What Type Of Shareholders Make Up Sinopharm Group Co., Ltd.'s (HKG:1099) Share Registry?

Dec 25
What Type Of Shareholders Make Up Sinopharm Group Co., Ltd.'s (HKG:1099) Share Registry?

Read This Before Buying Sinopharm Group Co., Ltd. (HKG:1099) Shares

Dec 15
Read This Before Buying Sinopharm Group Co., Ltd. (HKG:1099) Shares

We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Dec 04
We Think Sinopharm Group (HKG:1099) Can Stay On Top Of Its Debt

Sinopharm Group's (HKG:1099) Stock Price Has Reduced 43% In The Past Five Years

Nov 25
Sinopharm Group's (HKG:1099) Stock Price Has Reduced 43% In The Past Five Years

Rentabilidad de los accionistas

1099HK HealthcareMercado HK
7D-2.9%-1.3%1.2%
1Y-20.2%-28.6%0.9%

Rentabilidad vs. Industria: 1099 superó a la industria Hong Kong Healthcare, que obtuvo un rendimiento del -22.5% el año pasado.

Rentabilidad vs. Mercado: 1099 obtuvo unos resultados inferiores a los del mercado Hong Kong, que fueron del -1.8% el año pasado.

Volatilidad de los precios

Is 1099's price volatile compared to industry and market?
1099 volatility
1099 Average Weekly Movement4.9%
Healthcare Industry Average Movement5.4%
Market Average Movement6.8%
10% most volatile stocks in HK Market14.5%
10% least volatile stocks in HK Market3.6%

Precio estable de las acciones: 1099 no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 1099 (5%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
2003115,959Yong Liuwww.sinopharmgroup.com.cn

Sinopharm Group Co. Ltd., junto con sus filiales, se dedica a la venta al por mayor y al por menor de productos farmacéuticos, dispositivos médicos y productos sanitarios en la República Popular China. La empresa opera a través de cuatro segmentos: Distribución Farmacéutica, Dispositivos Médicos, Farmacia Minorista y Otros Negocios. El segmento de Distribución Farmacéutica distribuye productos farmacéuticos a hospitales, otros distribuidores, farmacias minoristas y clínicas.

Resumen de fundamentos de Sinopharm Group Co. Ltd.

¿Cómo se comparan los beneficios e ingresos de Sinopharm Group con su capitalización de mercado?
Estadísticas fundamentales de 1099
Capitalización bursátilHK$59.98b
Beneficios(TTM)HK$9.54b
Ingresos (TTM)HK$642.60b

6.3x

Ratio precio-beneficio (PE)

0.1x

Ratio precio-ventas (PS)

¿Está 1099 sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 1099
IngresosCN¥598.32b
Coste de los ingresosCN¥550.17b
Beneficio brutoCN¥48.15b
Otros gastosCN¥39.26b
BeneficiosCN¥8.88b

Últimos beneficios comunicados

Mar 31, 2024

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)2.85
Margen bruto8.05%
Margen de beneficio neto1.48%
Ratio deuda/patrimonio62.9%

¿Cómo se ha desempeñado 1099 a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

5.0%

Rentabilidad actual por dividendo

31%

Ratio de pagos